BIOMIRA INC. ANNOUNCES NASDAQ LISTING
BIOMIRA INC. ANNOUNCES NASDAQ LISTING EDMONTON, Alberta, Nov. 8 /PRNewswire/ - Biomira Inc.
(Toronto, Montreal, Alberta: BRA) announced today that its presently outstanding common shares have been approved for quotation in the United States on the National Market System (NMS) of the National Association of Securities Dealers Automated Quotation System (NASDAQ) under the symbol "BIOMF." Trading on NASDAQ (NMS) is expected to commence no later than Nov. 19, 1991.
Separately, it was announced that SoundView Financial Group, Inc. of Stamford Connecticut would be joining ScotiaMcLeod (USA) Inc. as an underwriter of the United States portion of Biomira's previously announced proposed cross-border public offering of approximately 4,000,000 common shares. The offering of these new common shares is expected to close during December 1991. The registration statement filed in the United States with the Securities and Exchange Commission with respect to the proposed new issue of common shares has not yet become effective. Accordingly these new common shares may not be sold nor may offers to buy be accepted in the United States prior to the time the registration statement becomes effective, and in Canada prior to receipts being obtained for the final prospectus from the appropriate securities commissions and other regulatory authorities. This announcement shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there by any sale of the new common shares in any Canadian province or state of the United States, in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such province or state. Biomira Inc., a public biotechnology company listed on the Toronto, Montreal and Alberta stock exchanges (symbol "BRA") is focused on the research, development and commercialization of cancer diagnostic and therapeutic products. Biomira currently markets four in vitro diagnostic kits for gastrointestinal, ovarian and breast cancer under the TRUQUANT label. -0- 11/8/91 /CONTACT: James E. Devaney, VP-Finance, or Alex McPherson, president and chief executive officer, Biomira Inc., 403-450-3761/ (BIOMF BRA.) CO: Biomira Inc. ST: Alberta IN: MTC SU: KJ -- LA011 -- 2600 11/08/91 12:41 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Nov 8, 1991|
|Previous Article:||SANTA FE TO ACQUIRE 90 GE LOCOMOTIVES|
|Next Article:||MARLTON TECHNOLOGIES ANNOUNCES 1991 THIRD QUARTER EARNINGS|